In this Issue:
AF and stroke in sleep-disordered breathing
Temporary interruptions of rivaroxaban vs. warfarin in NVAF
Antiarrhythmic therapy in AF treated with oral anticoagulants
Antihypertensives and AF risk
Details of trial of rivaroxaban for preventing cardiovascular events in NVAF scheduled for cardioversion
Ventricular rate for predicting AF-related inappropriate ICD shocks
AF risk with oral and IV bisphosphonates
LA wall thickness and catheter ablation for AF in hypertrophic cardiomyopathy
Safety of oral anticoagulants in AF ablation
Dronedarone for AF/atrial flutter
Please login below to download this issue (PDF)